Flanagan M - Search Results

1

Coronary bypass surgery for acute coronary insufficiency resistant to medical treatment.

Blake S, McCarthy C, Neligan M, O'Malley E, McCann P, O'Neill H, Smith P, Kenny J, Flanagan M, Ahearne T, Bonar F, Branagan P, Luke D, Garrett J. Blake S, et al. Among authors: flanagan m. Ir Med J. 1982 Oct;75(10):367-9. Ir Med J. 1982. PMID: 6983512 No abstract available.

2

The diagnosis and treatment of constrictive pericarditis.

Drury I, Hanley P, Blake S, O'Malley E, Neligan M, McCarthy C, Garrett J, Bonar F, Branagan P, Flanagan M, Kirwan M. Drury I, et al. Among authors: flanagan m. Ir Med J. 1983 Apr;76(4):171-2, 174. Ir Med J. 1983. PMID: 6862829 No abstract available.

3

Valve replacement for aortic valve disease.

Flanagan M, Kirwan M, Blake S, Counihan TB, McCann P, McCarthy C, Neligan M, O'Malley E, Bergin A, Brennan F, et al. Flanagan M, et al. Ir Med J. 1983 Aug;76(8):338-40. Ir Med J. 1983. PMID: 6618842 No abstract available.

4

Cardiac constriction due to malignant disease of the pericardium.

Kirwan M, Blake S, Neligan M, O'Malley E, Bergin A, Bonar F, Flanagan M, Garrett J, Griffin B, Whelan D. Kirwan M, et al. Among authors: flanagan m. Ir J Med Sci. 1983 Dec;152(12):454-5. doi: 10.1007/BF02958709. Ir J Med Sci. 1983. PMID: 6365833 No abstract available.

5

Aetiology of chronic constrictive pericarditis.

Blake S, Bonar S, O'Neill H, Hanly P, Drury I, Flanagan M, Garrett J. Blake S, et al. Among authors: flanagan m. Br Heart J. 1983 Sep;50(3):273-6. doi: 10.1136/hrt.50.3.273. Br Heart J. 1983. PMID: 6615663 Free PMC article.

6

Pregnancy with constrictive pericarditis. Case reports.

Blake S, Bonar F, MacDonald D, McCarthy JR, Flanagan M, Garrett J, Kirwan M. Blake S, et al. Among authors: flanagan m. Br J Obstet Gynaecol. 1984 Apr;91(4):404-6. doi: 10.1111/j.1471-0528.1984.tb05934.x. Br J Obstet Gynaecol. 1984. PMID: 6712902 No abstract available.

7

Nifedipine in the treatment of hypertension.

Brennan F, Flanagan M, Blake S, Cannon P. Brennan F, et al. Among authors: flanagan m. Eur J Clin Pharmacol. 1983;25(6):713-5. doi: 10.1007/BF00542507. Eur J Clin Pharmacol. 1983. PMID: 6363097

8

An alternative mechanism for the inhibition of cholesterol biosynthesis in HepG2 cells by N-[(1,5,9)-trimethyldecyl]-4 alpha,10-dimethyl-8-aza-trans-decal-3 beta-ol (MDL 28,815).

Van Sickle WA, Wilson PK, Wannamaker MW, Cooper JR, Flanagan MA, McCarthy JR, Bey P, Jackson RL. Van Sickle WA, et al. Among authors: flanagan ma. J Pharmacol Exp Ther. 1993 Dec;267(3):1243-9. J Pharmacol Exp Ther. 1993. PMID: 8263786

9

Inhibition of cholesterol synthesis by cyclopropylamine derivatives of squalene in human hepatoblastoma cells in culture.

Van Sickle WA, Angelastro MR, Wilson P, Cooper JR, Marquart A, Flanagan MA. Van Sickle WA, et al. Among authors: flanagan ma. Lipids. 1992 Mar;27(3):157-60. doi: 10.1007/BF02536171. Lipids. 1992. PMID: 1326069

10

Regulation of hepatic lipase expression by an intermediate of the cellular cholesterol biosynthetic pathway.

Busch SJ, Martin GA, Barnhart RL, Flanagan MA, Jackson RL. Busch SJ, et al. Among authors: flanagan ma. Adv Exp Med Biol. 1991;285:65-9. doi: 10.1007/978-1-4684-5904-3_7. Adv Exp Med Biol. 1991. PMID: 1650119 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

649 results

Search Page